{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:01:45Z","timestamp":1787997705667,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"German Federal Ministry of Education and Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejpb.2016.11.028","type":"journal-article","created":{"date-parts":[[2016,11,27]],"date-time":"2016-11-27T06:45:48Z","timestamp":1480229148000},"page":"187-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Effects of frequently used pharmaceutical excipients on the organic cation transporters 1\u20133 and peptide transporters 1\/2 stably expressed in MDCKII cells"],"prefix":"10.1016","volume":"112","author":[{"given":"Marcus","family":"Otter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.11.028_b0005","series-title":"Advances in Pharmaceutical Technology","article-title":"Drug delivery strategies for poorly water-soluble drugs","author":"Douroumis","year":"2013"},{"issue":"12","key":"10.1016\/j.ejpb.2016.11.028_b0010","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1517\/17425240903307423","article-title":"Recent advances in intravenous delivery of poorly water-soluble compounds","volume":"6","author":"Shi","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.11.028_b0015","series-title":"AAPS Advances in the Pharmaceutical Sciences Series 3","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-1144-4","article-title":"Formulating poorly water soluble drugs","author":"Williams","year":"2012"},{"issue":"1","key":"10.1016\/j.ejpb.2016.11.028_b0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.383","article-title":"In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam","volume":"25","author":"Gonz\u00e1lez","year":"2004","journal-title":"Biopharm. Drug Dispos."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2016.11.028_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.08.021","article-title":"Effect of excipients on breast cancer resistance protein substrate uptake activity","volume":"124","author":"Yamagata","year":"2007","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"issue":"2","key":"10.1016\/j.ejpb.2016.11.028_b0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejpb.2010.06.008","article-title":"Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2)","volume":"76","author":"Hanke","year":"2010","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arbeitsgemeinschaft f\u00fcr Pharmazeutische Verfahrenstechnik e.V"},{"issue":"1","key":"10.1016\/j.ejpb.2016.11.028_b0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-3659(03)00163-9","article-title":"Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines","volume":"90","author":"Lo","year":"2003","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"issue":"1","key":"10.1016\/j.ejpb.2016.11.028_b0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2010.12.033","article-title":"Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro","volume":"78","author":"Christiansen","year":"2011","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arbeitsgemeinschaft f\u00fcr Pharmazeutische Verfahrenstechnik e.V"},{"issue":"4","key":"10.1016\/j.ejpb.2016.11.028_b0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jcph.24","article-title":"Effect of excipients on acetaminophen metabolism and its implications for prevention of liver injury","volume":"53","author":"Ganetsky","year":"2013","journal-title":"J. Clin. Pharmacol."},{"issue":"15","key":"10.1016\/j.ejpb.2016.11.028_b0050","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.addr.2007.08.017","article-title":"The effects of pharmaceutical excipients on drug disposition","volume":"59","author":"Buggins","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.ejpb.2016.11.028_b0055","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1021\/mp3001815","article-title":"Pharmaceutical excipients influence the function of human uptake transporting proteins","volume":"9","author":"Engel","year":"2012","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2016.11.028_b0060","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejpb.2016.11.028_b0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development. Nature reviews.","volume":"9","author":"Giacomini","year":"2010","journal-title":"Drug Discov."},{"issue":"1","key":"10.1016\/j.ejpb.2016.11.028_b0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2013.74","article-title":"Emerging transporters of clinical importance: an update from the International Transporter Consortium","volume":"94","author":"Hillgren","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2016.11.028_b0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-642-14541-4_3","article-title":"Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.","volume":"201","author":"Nies","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejpb.2016.11.028_b0080","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharm. Res."},{"issue":"Suppl 6","key":"10.1016\/j.ejpb.2016.11.028_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ndt\/15.suppl_6.11","article-title":"Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2","volume":"15","author":"Inui","year":"2000","journal-title":"Nephrol., Dial., Transplant.: Off. Publ. Eur. Dial. Transpl. Assoc. \u2013 Eur. Renal Assoc."},{"issue":"1","key":"10.1016\/j.ejpb.2016.11.028_b0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejpb.2004.07.008","article-title":"Interaction of 31 beta-lactam antibiotics with the H+\/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1","volume":"59","author":"Luckner","year":"2005","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arbeitsgemeinschaft f\u00fcr Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.ejpb.2016.11.028_b0095","series-title":"Controlled Pulmonary Drug Delivery","author":"Smyth","year":"2011"},{"issue":"6","key":"10.1016\/j.ejpb.2016.11.028_b0100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4155\/tde.12.51","article-title":"Organic cation transporters in the blood\u2013air barrier: expression and implications for pulmonary drug delivery","volume":"3","author":"Salomon","year":"2012","journal-title":"Therap. Deliv."},{"issue":"5","key":"10.1016\/j.ejpb.2016.11.028_b0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1211\/jpp.60.5.0002","article-title":"Pharmaceutical and pharmacological importance of peptide transporters","volume":"60","author":"Brandsch","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejpb.2016.11.028_b0110","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/FPC.0b013e3283559b22","article-title":"Metformin pathways: pharmacokinetics and pharmacodynamics","volume":"22","author":"Gong","year":"2012","journal-title":"Pharmacogenet. Genom."},{"issue":"6","key":"10.1016\/j.ejpb.2016.11.028_b0115","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.coph.2013.08.004","article-title":"Drug transport via the intestinal peptide transporter PepT1","volume":"13","author":"Brandsch","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejpb.2016.11.028_b0120","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.ajpath.2011.02.020","article-title":"Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy","volume":"178","author":"Grube","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejpb.2016.11.028_b0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpba.2013.07.031","article-title":"LC\u2013MS\/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins","volume":"85","author":"Gr\u00f6er","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"8","key":"10.1016\/j.ejpb.2016.11.028_b0130","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"key":"10.1016\/j.ejpb.2016.11.028_b0135","article-title":"Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue","author":"Brueck","year":"2016","journal-title":"Biopharm. Drug Dispos."},{"issue":"4","key":"10.1016\/j.ejpb.2016.11.028_b0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/dmd.105.006791","article-title":"Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters","volume":"34","author":"Li","year":"2006","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"key":"10.1016\/j.ejpb.2016.11.028_b0145","series-title":"Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems","year":"2006"},{"issue":"9","key":"10.1016\/j.ejpb.2016.11.028_b0150","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1023\/A:1020315228237","article-title":"Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine","volume":"19","author":"Basit","year":"2002","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.ejpb.2016.11.028_b0155","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1023\/B:PHAM.0000008046.64409.bd","article-title":"Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption","volume":"20","author":"Schulze","year":"2003","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2016.11.028_b0160","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/jpet.105.091223","article-title":"Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)","volume":"315","author":"Bourdet","year":"2005","journal-title":"J. Pharmacol. Exp. Therap."},{"issue":"2","key":"10.1016\/j.ejpb.2016.11.028_b0165","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/mol.112.084517","article-title":"Organic cation transporter 1 (OCT1\/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes","volume":"84","author":"Han","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejpb.2016.11.028_b0170","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","article-title":"Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)","volume":"70","author":"M\u00fcller","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejpb.2016.11.028_b0175","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF02969273","article-title":"The transport of organic cations in the small intestine: current knowledge and emerging concepts","volume":"29","author":"Kim","year":"2006","journal-title":"Arch. Pharmacal Res."},{"issue":"16","key":"10.1016\/j.ejpb.2016.11.028_b0180","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1128\/MCB.21.16.5471-5477.2001","article-title":"Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene","volume":"21","author":"Jonker","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2016.11.028_b0185","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2011.02.059","article-title":"The effect of polyoxyethylene polymers on the transport of ranitidine in Caco-2 cell monolayers","volume":"409","author":"Ashiru-Oredope","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2016.11.028_b0190","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/0016-5085(89)91686-7","article-title":"Mechanisms of polyethylene glycol 400 permeability of perfused rat intestine","volume":"97","author":"Krugliak","year":"1989","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejpb.2016.11.028_b0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600830432","article-title":"Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice","volume":"83","author":"Yamaoka","year":"1994","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2016.11.028_b0200","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/A:1012136608249","article-title":"Cyclodextrins: their future in drug formulation and delivery","volume":"14","author":"Stella","year":"1997","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2016.11.028_b0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0192623307310945","article-title":"Cyclodextrins","volume":"36","author":"Stella","year":"2008","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.ejpb.2016.11.028_b0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1570180053765165","article-title":"Impact of oral administration of the surface-active excipient solutol HS 15 on the pharmacokinetics of intravenously administered colchicine","volume":"2","author":"Bittner","year":"2005","journal-title":"LDDD"},{"issue":"20","key":"10.1016\/j.ejpb.2016.11.028_b0215","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/jnci\/85.20.1685","article-title":"Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype","volume":"85","author":"Webster","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.ejpb.2016.11.028_b0220","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00280-002-0531-6","article-title":"Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat","volume":"50","author":"Liu","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejpb.2016.11.028_b0225","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1158\/1078-0432.CCR-07-4903","article-title":"A phase I and pharmacokinetic study of weekly oxaliplatin followed by paclitaxel in patients with solid tumors","volume":"14","author":"Bekaii-Saab","year":"2008","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejpb.2016.11.028_b0230","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/annonc\/mdj097","article-title":"A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients","volume":"17","author":"Viens","year":"2006","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol.\/ESMO"},{"issue":"17","key":"10.1016\/j.ejpb.2016.11.028_b0235","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1158\/0008-5472.CAN-06-0769","article-title":"Organic cation transporters are determinants of oxaliplatin cytotoxicity","volume":"66","author":"Zhang","year":"2006","journal-title":"Cancer Res."},{"issue":"27","key":"10.1016\/j.ejpb.2016.11.028_b0240","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1305321110","article-title":"Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2","volume":"110","author":"Sprowl","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ejpb.2016.11.028_b0245","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1124\/dmd.108.023168","article-title":"Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer","volume":"36","author":"Yokoo","year":"2008","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"issue":"2","key":"10.1016\/j.ejpb.2016.11.028_b0250","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/jpet.106.110346","article-title":"Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)","volume":"319","author":"Yonezawa","year":"2006","journal-title":"J. Pharmacol. Exp. Therap."},{"issue":"4","key":"10.1016\/j.ejpb.2016.11.028_b0255","first-page":"1205","article-title":"Clinical pharmacokinetics of oxaliplatin: a critical review","volume":"6","author":"Graham","year":"2000","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"9","key":"10.1016\/j.ejpb.2016.11.028_b0260","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF02976689","article-title":"Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats","volume":"26","author":"Zhang","year":"2003","journal-title":"Arch. Pharmacal Res."},{"issue":"3","key":"10.1016\/j.ejpb.2016.11.028_b0265","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF00258124","article-title":"The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80","volume":"14","author":"Azmin","year":"1985","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2016.11.028_b0270","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00299871","article-title":"Influence of polysorbate 80 (Tween 80) and etoposide (VP-16-213) on the pharmacokinetics and urinary excretion of adriamycin and its metabolites in cancer patients","volume":"17","author":"Cummings","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejpb.2016.11.028_b0275","doi-asserted-by":"crossref","first-page":"20508","DOI":"10.1038\/srep20508","article-title":"The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin","volume":"6","author":"Andreev","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejpb.2016.11.028_b0280","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/bjc.1996.90","article-title":"Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice","volume":"73","author":"Webster","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.ejpb.2016.11.028_b0285","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00001813-199810000-00011","article-title":"Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice","volume":"9","author":"Badary","year":"1998","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.ejpb.2016.11.028_b0290","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0169-409X(02)00176-X","article-title":"Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier","volume":"55","author":"Kabanov","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2016.11.028_b0295","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jps.2600630136","article-title":"CMC of polysorbates","volume":"63","author":"Wan","year":"1974","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.11.028_b0300","series-title":"Drug Delivery Research Advances","author":"Mashkevich","year":"2007"},{"issue":"3","key":"10.1016\/j.ejpb.2016.11.028_b0305","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0006-3495(02)75499-4","article-title":"Direct observation of poloxamer 188 insertion into lipid monolayers","volume":"82","author":"Maskarinec","year":"2002","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.ejpb.2016.11.028_b0310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02894385","article-title":"A review of block polymer surfactants","volume":"54","author":"Schmolka","year":"1977","journal-title":"J. Am. Oil Chem. Soc."},{"issue":"1 Suppl","key":"10.1016\/j.ejpb.2016.11.028_b0315","first-page":"91","article-title":"Surfactant poloxamer 188-related decreases in inflammation and tissue damage after experimental brain injury in rats","volume":"101","author":"Curry","year":"2004","journal-title":"J. Neurosurg."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116308645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116308645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T12:27:23Z","timestamp":1656937643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116308645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":63,"alternative-id":["S0939641116308645"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.11.028","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of frequently used pharmaceutical excipients on the organic cation transporters 1\u20133 and peptide transporters 1\/2 stably expressed in MDCKII cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}